Onkos Surgical Marks 1,000th Personalized My3D Pelvic Implant Case

Onkos Surgical revealed that the 1,000^th case using its personalized My3D patient-specific pelvic implant platform has been completed.

The milestone highlights the use of 3D printing and personalized approaches for complex orthopedic cases involving anatomical variation, bone loss, tumors, or revision procedures. Through its My3D platform, Onkos combines case planning, advanced imaging, 3D anatomical modeling, and patient-specific implant design to support surgical planning and execution.

The platform also offers competitive delivery times and costs for personalized pelvis reconstruction.

The My3D platform received FDA 510(k) clearance in 2022 and includes patient-specific implants for acetabular and complex pelvic reconstruction. The implants feature designs intended to address bone and soft-tissue attachment and support accurate anatomical restoration.

In June, the company earned a 510(k) nod for use of its NanoCept Antibacterial Technology on titanium implants in the ELEOS Limb Salvage System.

Comments from Onkos execs and clinicians

Jeff Barry, MD, associate professor of Orthopedic Surgery, director of the Adult Reconstruction Hip and Knee Fellowship, UCSF Department of Orthopaedic Surgery: “Pelvic and acetabular reconstruction is an ideal procedure to leverage cutting-edge digital planning and personalized implants. Patient-specific implant solutions can provide surgeons with an important reconstructive option when treating cases where standard approaches may not provide an adequate treatment to address the patient’s anatomy or reconstruction goals. This product is the future of acetabular revision surgery, available now.”

Onkos Director of Patient Solutions Rick Swanson: “Reaching 1,000 My3D Pelvis cases represents more than a milestone, it reflects the knowledge and expertise our engineers have developed through close collaboration with surgeons. The clinical insights gathered from each case continue to strengthen our personalized design process and support future surgeon-led planning sessions.”

Onkos Founder/CEO Patrick Treacy: “Reaching the 1,000th personalized My3D pelvic implant case is a meaningful milestone for Onkos and for the surgeons who partner with us on solutions for their patientsOur personalized approach is built around understanding each patient’s unique anatomy and helping surgeons translate that understanding into a thoughtful reconstruction plan.”

Find out more about Onkos Surgical founder and CEO Patrick Treacy here!